Image Of 8 mg Package Label (4767)
Doxazosin
Product Images NDC 54868-4802
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 54868-4802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image Of 2 mg Package Label (4801)
Do not available.*
Image Of 4 mg Package Label (4802)
This is a prescription drug called Doxazosin Mesylate, which comes in tablet form with a strength of 4mg. The label suggests it is intended for use by physicians for total care. The remaining text appears to be errors from and is not readable.*
Image Of 1 mg Package Label (4895)
Image Of Chemical Structure (Chemical Structure)
Image Of Figure 1 (Figure 1)
Image Of Table 1 (Table 1)
This text describes the results of three studies on the efficacy of Doazosin in the treatment of benign prostatic hyperplasia (BPH) and hypertension. The maximum flow rate and symptom scores were determined after administering either a placebo or Doazosin. Study 1 involved a titration to a maximum dose of 8mg while Study 2 had a fixed dose for 14 weeks. Study 3 had a titration to a fixed dose for 12 weeks. In all studies, the results showed that Doazosin was more effective in improving maximum flow rate and symptom scores compared to placebo. The text also notes that 236 patients received a dose of 8 mg dokazosin.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
